Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-UT) for Thin Endometrial Infertility
NCT05495711Phase 1Completed
- Sponsor
- Sclnow Biotechnology Co., Ltd.
- Start
- Aug 2022
- Primary completion
- Jun 2023
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of iSCLife-UT in infertility (2 arms), sponsored by Sclnow Biotechnology Co., Ltd. Primary endpoint: Pregnancy outcome at 12 months. Started Aug 2022; status: completed.
02
Drugs
iSCLife-UT
03
Conditions
infertility
Beyond the preview
Go deeper on NCT05495711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05495711.